Caranx Medical
FranceFDA applicant, unverified FDA FEI 3021561977
- Devices
- 1
- Registrations
- FDA
- FDA recalls
- 0
At a glance
Market reach
- United States
- FDA FEI
What Caranx Medical makes
Caranx Medical develops the TAVIPILOT, a transcatheter aortic valve implantation (TAVI) delivery system designed to assist in the placement of transcatheter heart valves within the aortic position.
The TAVIPILOT is classified as a Class II medical device in the US and is listed under the FDA’s 510(k) premarket notification process. The company is based in the United States.
Catalogue
Tavipilot Ref K243884
Regimes: 510(k) Registry: 510(k)
Company details
- FDA FEI number
- 3021561977
- Address
- 400 Promenade des Anglais, Nice Provence-Alpes-Cote d'Azur
Frequently asked questions
How many devices does Caranx Medical have in the registry?
The registry currently lists 1 device for Caranx Medical. Devices recorded under merged duplicate company entries are counted once.
Which registries list Caranx Medical's devices?
Among its 1 most recently registered device, Caranx Medical has devices listed in FDA 510(k) (1 device).
What risk classes do Caranx Medical's devices fall under?
Among its 1 most recently registered device, the classes recorded for Caranx Medical's devices are Class II. Each device page shows its own class and authorisation.
What are the newest devices from Caranx Medical in the registry?
The most recently registered devices listed for Caranx Medical include TAVIPILOT.